288 related articles for article (PubMed ID: 24665862)
1. Management of fatty liver disease with the metabolic syndrome.
Machado MV; Cortez-Pinto H
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):487-500. PubMed ID: 24665862
[TBL] [Abstract][Full Text] [Related]
2. Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.
Vanni E; Marengo A; Mezzabotta L; Bugianesi E
Semin Liver Dis; 2015 Aug; 35(3):236-49. PubMed ID: 26378641
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
Williams T
FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
[TBL] [Abstract][Full Text] [Related]
4. A concise review of non-alcoholic fatty liver disease.
Than NN; Newsome PN
Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic effects of antidiabetic drugs in non-alcoholic fatty liver disease.
Rix I; Steen Pedersen J; Storgaard H; Gluud LL
Clin Physiol Funct Imaging; 2019 Mar; 39(2):122-127. PubMed ID: 29808958
[TBL] [Abstract][Full Text] [Related]
6. A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
Targher G; Byrne CD
Metab Syndr Relat Disord; 2015 Aug; 13(6):235-8. PubMed ID: 25714786
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease as a multi-systemic disease.
Fotbolcu H; Zorlu E
World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
[TBL] [Abstract][Full Text] [Related]
9. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
[TBL] [Abstract][Full Text] [Related]
10. [NASH (non-alcoholic steatohepatitis): fatty liver or fatal liver disease?].
Roeb E
Zentralbl Chir; 2014 Apr; 139(2):168-74. PubMed ID: 22441997
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
Edens MA; Kuipers F; Stolk RP
Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease following liver transplantation: a clinical review.
Merola J; Liapakis A; Mulligan DC; Yoo PS
Clin Transplant; 2015 Sep; 29(9):728-37. PubMed ID: 26147308
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
Mikolasevic I; Racki S; Lukenda V; Pavletic-Persic M; Milic S; Orlic L
Med Hypotheses; 2014 Jan; 82(1):36-9. PubMed ID: 24280560
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
Luo J; Xu L; Li J; Zhao S
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
[TBL] [Abstract][Full Text] [Related]
15. Treatment of non-alcoholic fatty liver disease.
Dyson J; Day C
Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
[TBL] [Abstract][Full Text] [Related]
16. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
17. Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome.
Pacifico L; Giansanti S; Gallozzi A; Chiesa C
Mini Rev Med Chem; 2014; 14(10):791-804. PubMed ID: 25307311
[TBL] [Abstract][Full Text] [Related]
18. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
19. Managing non-alcoholic fatty liver disease.
Ngu JH; Goh GB; Poh Z; Soetikno R
Singapore Med J; 2016 Jul; 57(7):368-71. PubMed ID: 27439352
[TBL] [Abstract][Full Text] [Related]
20. NAFLD: a multisystem disease.
Byrne CD; Targher G
J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
